메뉴 건너뛰기




Volumn 70, Issue 4, 2008, Pages 477-481

Development and in vitro evaluation of enteric coated multiparticulate system for resistant tuberculosis

Author keywords

Enteric coated; Eudragit L 30 D55; Extrusion spheronization; Fluidized bed coater; Pellets

Indexed keywords

ACRYLIC ACID; AMINOSALICYLIC ACID; EUDRAGIT; MICROCRYSTALLINE CELLULOSE;

EID: 58149101682     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.44597     Document Type: Article
Times cited : (22)

References (8)
  • 1
    • 0026608368 scopus 로고
    • Biopharmaceutical comparison of an oral multiple unit and single unit sustained -release dosage forms
    • Follonier N, Doelker E. Biopharmaceutical comparison of an oral multiple unit and single unit sustained -release dosage forms. STP Pharma Sci 1992;2:141-58.
    • (1992) STP Pharma Sci , vol.2 , pp. 141-158
    • Follonier, N.1    Doelker, E.2
  • 2
    • 0141792507 scopus 로고    scopus 로고
    • The influence of polymeric subcoat and pellet formulation on the release of chlorpheniramine maleate from Enteric coated pellets
    • Bruce LD, Koleng JJ, McGinity WJ. The influence of polymeric subcoat and pellet formulation on the release of chlorpheniramine maleate from Enteric coated pellets. Drug Develop Ind Pharm 2003;29:909-24.
    • (2003) Drug Develop Ind Pharm , vol.29 , pp. 909-924
    • Bruce, L.D.1    Koleng, J.J.2    McGinity, W.J.3
  • 3
    • 0033053836 scopus 로고    scopus 로고
    • Influence of aqueous coatings on the stability of enteric coated pellets and tablets
    • Thoma K, Bechtold K. Influence of aqueous coatings on the stability of enteric coated pellets and tablets. Eur J Pharm Biopharm 1999;47:39-50.
    • (1999) Eur J Pharm Biopharm , vol.47 , pp. 39-50
    • Thoma, K.1    Bechtold, K.2
  • 4
    • 0025744237 scopus 로고
    • Technology evaluation of aqueous enteric coating systems with and without insoluble additives
    • Bianchini R, Resciniti M, Vecchio C. Technology evaluation of aqueous enteric coating systems with and without insoluble additives. Drug Develop Ind Pharm 1991;17:1779-94.
    • (1991) Drug Develop Ind Pharm , vol.17 , pp. 1779-1794
    • Bianchini, R.1    Resciniti, M.2    Vecchio, C.3
  • 6
    • 0035158137 scopus 로고    scopus 로고
    • Development of an enteric coating formulation and process for tablets primarily composed of a highly water soluble organic acid
    • Crotts G, Sheth A, Tweist J, Ghebre-Sellassie I. Development of an enteric coating formulation and process for tablets primarily composed of a highly water soluble organic acid. Eur J Pharm Biopharm 2001;51:71-6.
    • (2001) Eur J Pharm Biopharm , vol.51 , pp. 71-76
    • Crotts, G.1    Sheth, A.2    Tweist, J.3    Ghebre-Sellassie, I.4
  • 7
    • 0000282721 scopus 로고
    • Modified drug release from beads prepared with combinations of two grades of microcrystalline cellulose
    • Ghali ES, Klinger GH. Modified drug release from beads prepared with combinations of two grades of microcrystalline cellulose. Drug Develop Ind Pharm 1989;15:1455-73.
    • (1989) Drug Develop Ind Pharm , vol.15 , pp. 1455-1473
    • Ghali, E.S.1    Klinger, G.H.2
  • 8
    • 0031033983 scopus 로고    scopus 로고
    • The influence of five selected processing and formulation variables on the particle size, particle size distribution and friability of pellets produced in a rotary processor
    • Vertomme, J, Kinget R. The influence of five selected processing and formulation variables on the particle size, particle size distribution and friability of pellets produced in a rotary processor. Drug Develop Ind Pharm 1997;23:39-46.
    • (1997) Drug Develop Ind Pharm , vol.23 , pp. 39-46
    • Vertomme, J.1    Kinget, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.